Man wearing a face mask
·
3 MIN READ

New policies on treating pain, OUD emerge from COVID-19 crisis

The DEA is allowing qualified physicians to prescribe buprenorphine over the telephone so patients can stay home. The AMA urges states to do the same.

Overdose Epidemic
·
1 MIN READ

AMA urges governors to adopt DEA guidance for opioid use disorder

This guidance removes a considerable barrier for many patients during the COVID-19 national emergency and, importantly, allows them to stay at home.

Press Releases
Patient speaking with physician
·
4 MIN READ

New York effort raises use of MAT for opioid-use disorder

Medications for addiction treatment (MAT) are underused, with racial, geographic and economic barriers. Learn about a Big Apple initiative that’s making big changes.

Overdose Epidemic
·
3 MIN READ

After his son’s death, Massachusetts physician seeks to help others

James Baker, MD, whose son died of an overdose at 23, provides phone support to primary care doctors treating patients with substance-use disorders.

Overdose Epidemic
·
5 MIN READ

Feb. 28, 2020: State Advocacy Update

Warning on naloxone in CO, prior authorization in ME and more in AMA's latest state advocacy efforts.

Advocacy Update
·
3 MIN READ

Removing prior authorization for MAT results in more patient care

Learn how Maryland has changed the law to help patients with opioid-use disorder get the evidence-based care they need.

Prior Authorization
·
8 MIN READ

Health care 2020: Here’s where Congress and the states are headed

The AMA’s senior VP of advocacy offers expert insight on what physicians should expect, and advises doctors looking to make a mark with policymakers.

Access to Care
·
3 MIN READ

Saving time and lives by increased access to MAT in Pennsylvania

John Gallagher, MD, asked policymakers the hard questions about why barriers to effective treatment were allowed to persist.

Prior Authorization
Dr. Patrice Harris speaking at an event
·
4 MIN READ

Changes overdue on how substance-use disorders are covered, treated

The AMA is “laser-focused” on removing barriers to treatment for opioid-use disorder—including eliminating stigma, says the organization’s president, Patrice A. Harris, MD, MA.

Overdose Epidemic